LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 2ACEBUTOLOL HYDROCHLORIDE
02 1ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE
03 2AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
04 1BUTALBITAL AND ACETAMINOPHEN
05 3BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
06 1BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
07 2BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
08 1COXANTO
09 1DANAZOL
10 1DOXYCYCLINE HYCLATE
11 1FLUOXETINE HYDROCHLORIDE
12 2INDOMETHACIN
13 2LITHIUM CARBONATE
14 1OSELTAMIVIR PHOSPHATE
15 1OXYCODONE AND ACETAMINOPHEN
16 1OXYCODONE HYDROCHLORIDE
17 2PHENTERMINE HYDROCHLORIDE
18 1RIVASTIGMINE TARTRATE
19 1SELEGILINE HYDROCHLORIDE
20 1SYNALGOS-DC
21 1SYPRINE
22 1TEMODAR
23 8TEMOZOLOMIDE
24 1TERAZOSIN HYDROCHLORIDE
25 1TETRACYCLINE HYDROCHLORIDE
26 2TIZANIDINE HYDROCHLORIDE
27 1TREZIX
28 1TRIENTINE HYDROCHLORIDE
29 1ZANAFLEX
30 1ZONISAMIDE
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Drug : BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
Dosage Form : CAPSULE; ORAL
Application Number : 76560
Country : US
Patented : No
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Drug : BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
Dosage Form : CAPSULE; ORAL
Application Number : 75231
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Drug : BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Dosage Form : CAPSULE; ORAL
Application Number : 210817
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : BUTALBITAL AND ACETAMINOPHEN
Dosage Form : CAPSULE; ORAL
Application Number : 207313
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Drug : BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
Dosage Form : CAPSULE; ORAL
Application Number : 203335
Country : US
Patented : No
